相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nature nurtures the design of new semi-synthetic macrolide antibiotics
Prabhavathi Fernandes et al.
JOURNAL OF ANTIBIOTICS (2017)
Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects
Borje Darpo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections
Stephen Hawser et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Results from the Solithromycin International Surveillance Program (2014)
David J. Farrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia
Thomas M. File et al.
CLINICAL INFECTIOUS DISEASES (2016)
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)
Carlos M. Barrera et al.
LANCET INFECTIOUS DISEASES (2016)
Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment
Brian D. Jamieson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Modified IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia Best Predicted Mortality
Hai-yan Li et al.
MEDICINE (2015)
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
Lorena Baietto et al.
CURRENT DRUG METABOLISM (2014)
Clinical and economic burden of community-acquired pneumonia among adults in Europe
T. Welte et al.
THORAX (2012)
Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects
J. Gordon Still et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis
Beatriz Llano-Sotelo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
分享论文
